Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Genomics Research Europe

Stephen Baylin's Biography

Stephen Baylin, Deputy Director, Johns Hopkins University School of Medicine

Stephen B. Baylin, M.D., is deputy director of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Virginia and D.K. Ludwig professor of oncology and medicine. He is chief of the Cancer Biology Division and associate director for research of the center.
Baylin attended Duke University, where he earned his medical degree in 1968 and completed his internship and first year residency in internal medicine. He then worked for two years at the National Heart and Lung Institute of the National Institutes of Health (NIH). In 1971, Baylin joined the departments of oncology and medicine at Johns Hopkins University School of Medicine.

His research interests include cellular biology and genetics of cancer, specifically epigenetics or genetic modifications other than those in DNA that can affect cell behavior, and silencing of tumor suppressor genes and tumor progression. His research has looked at the mechanisms through which variations in tumor cells derive, and cell differentiation in cancers such as medullary thyroid carcinoma and small cell lung carcinoma.

Baylin’s honors include the 2004 National Investigator of the Year Award from the NCI SPORE program; the 2005 Jack Gibson Visiting Professorship, University of Hong Kong Queen Mary Hospital, Hong Kong; the 2005 Shubitz Cancer Research Prize from the University of Chicago; the 2008 Raffaele Tecce Memorial Lecture, Rome, Italy; the 2008 David Workman Memorial Award from the Waxman Foundation; and the Kirk A. Landon-AACR Prize for Basic and Translational Cancer Research.

Baylin has served on the American Association for Cancer Research Board of Directors from 2004 through 2007, and is an associate editor of Cancer Research. He has also presented frequently at AACR conferences and chaired the special conference on "DNA Methylation, Imprinting and the Epigenetics of Cancer." Baylin has authored or co-authored more than 350 publications.

Stephen Baylin Image

DNA Methylation and the Cancer Epigenome Biological and Translations Implications

Tuesday, 4 September 2012 at 14:15

Add to Calendar ▼

We are in an exciting period of increased understanding of the molecular origins of epigenetic abnormalities in cancer. The resultant biological insights are increasingly important for developing strategies for “epigenetic therapies” for cancer and biomarker development.

Add to Calendar ▼2012-09-04 00:00:002012-09-05 00:00:00Europe/LondonGenomics Research EuropeGenomics Research Europe in Frankfurt, GermanyFrankfurt,